Nolpitantium Besylate In patients with mild to moderate Ulcerative Colitis: a double-blind, placebo-controlled Efficacy and safety, 8-week study.

Trial Profile

Nolpitantium Besylate In patients with mild to moderate Ulcerative Colitis: a double-blind, placebo-controlled Efficacy and safety, 8-week study.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 11 Aug 2011

At a glance

  • Drugs Nolpitantium (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Acronyms NICE
  • Sponsors Sanofi-Synthelabo
  • Most Recent Events

    • 11 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top